1. Home
  2. VABK vs ALLO Comparison

VABK vs ALLO Comparison

Compare VABK & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VABK
  • ALLO
  • Stock Information
  • Founded
  • VABK 1998
  • ALLO 2017
  • Country
  • VABK United States
  • ALLO United States
  • Employees
  • VABK N/A
  • ALLO N/A
  • Industry
  • VABK Major Banks
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VABK Finance
  • ALLO Health Care
  • Exchange
  • VABK Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • VABK 201.8M
  • ALLO 231.9M
  • IPO Year
  • VABK N/A
  • ALLO 2018
  • Fundamental
  • Price
  • VABK $38.50
  • ALLO $1.12
  • Analyst Decision
  • VABK
  • ALLO Strong Buy
  • Analyst Count
  • VABK 0
  • ALLO 10
  • Target Price
  • VABK N/A
  • ALLO $8.88
  • AVG Volume (30 Days)
  • VABK 32.3K
  • ALLO 4.4M
  • Earning Date
  • VABK 10-16-2025
  • ALLO 08-13-2025
  • Dividend Yield
  • VABK 3.47%
  • ALLO N/A
  • EPS Growth
  • VABK 14.13
  • ALLO N/A
  • EPS
  • VABK 3.31
  • ALLO N/A
  • Revenue
  • VABK $56,012,000.00
  • ALLO N/A
  • Revenue This Year
  • VABK N/A
  • ALLO N/A
  • Revenue Next Year
  • VABK N/A
  • ALLO $100.00
  • P/E Ratio
  • VABK $12.53
  • ALLO N/A
  • Revenue Growth
  • VABK 7.97
  • ALLO N/A
  • 52 Week Low
  • VABK $33.66
  • ALLO $0.86
  • 52 Week High
  • VABK $44.50
  • ALLO $3.78
  • Technical
  • Relative Strength Index (RSI)
  • VABK 46.00
  • ALLO 46.00
  • Support Level
  • VABK $41.13
  • ALLO $1.11
  • Resistance Level
  • VABK $42.94
  • ALLO $1.27
  • Average True Range (ATR)
  • VABK 2.29
  • ALLO 0.09
  • MACD
  • VABK -0.00
  • ALLO 0.01
  • Stochastic Oscillator
  • VABK 13.90
  • ALLO 46.43

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: